Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 37c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($0.95), $0.37 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• Farmmi announces public offering of Class A ordinary shares